Global Umbilical Blood (NYSE:CO) coverage was initiated at StockNews.com

Analysts at StockNews.com initiated coverage on the stock Global Umbilical Blood (NYSE:CO – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global performance of cord blood stocks

Global Cord Blood stock opened at $1.75 on Friday. The company has a market cap of $212.71 million, a price-to-earnings ratio of 2.73 and a beta of 0.16. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The stock has a fifty day moving average of $1.51 and a two hundred day moving average of $1.35.

Global Cord Blood Company Profile

(Get a free report)

Global Cord Blood operates as a holding company, engaged in the provision of cord blood banking services. Provides cord blood processing and storage services. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm stores cord blood units donated by the public and provides matching services on such donated units and provides matching units to patients in need of transplants.

Featured stories

Get news and reviews for Global Cord Blood Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Global Cord Blood and related companies with MarketBeat.com’s FREE daily email newsletter.